Avanti Biosciences is a private biotechnology company located in the Johnson & Johnson Innovation – JLABS incubator in San Diego.  

We focus our research on the discovery and development of innovative therapies for patients with debilitating diseases. Our strategy is to develop an efficient form of therapies designed to control complex diseases via new chemical entities (NCE) derived from natural products by making them more bio-available and selective. 

                 

Avanti's scientific founders are internationally recognized in the field of drug discovery and clinical development. They have an exceptional track record in identifying and translating new research into breakthrough science and therapeutics.

                 

The scientific discoveries of Avanti Biosciences have also the potential for applications in a wide range of other therapeutic indications including neurodegenerative disorders like Alzheimer's and Parkinson's disease, inflammation, and metabolic disorders like Nonalcoholic fatty liver disease (NAFLD).

At a Glance
  • Private R&D stage biotech company
  • Research focused on the treatment of unmet medical needs like:
    • Uveitis
    • NAFLD 
    • Alzheimer's Disease
    • Parkinson's Disease
  • Technology based on natural catechins that are major components of green tea 
  • Research is funded through private funds and NIH grants